UK markets open in 2 hours 35 minutes

Zevra Therapeutics, Inc. (ZVRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.7200-0.1000 (-2.07%)
At close: 04:00PM EDT
4.6500 -0.07 (-1.48%)
After hours: 06:53PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-39,917
-26,772
-8,555
-12,760
-24,522
Depreciation & amortisation
519
944
257
273
304
Stock-based compensation
4,036
4,294
2,436
2,491
4,410
Change in working capital
12,430
-406
-357
374
-5,120
Inventory
57
147
0
-
-
Other working capital
-22,097
-18,810
10,337
-1,972
-23,763
Other non-cash items
197
17,887
460
7,248
3,189
Net cash provided by operating activities
-21,839
-18,717
10,439
-1,939
-23,737
Cash flows from investing activities
Investments in property, plant and equipment
-258
-93
-102
-33
-26
Acquisitions, net
0
-14,090
0
-
-
Purchases of investments
-69,951
-23,861
-15,422
0
-
Sales/maturities of investments
-
-
-
0
3,260
Net cash used for investing activities
-28,038
-36,719
-15,524
-33
3,234
Cash flows from financing activities
Debt repayment
-12,808
-16
-38,097
-227
-207
Common stock issued
7,323
0
49,285
0
0
Common stock repurchased
-3,447
-4,723
-2,814
0
-
Other financing activities
330
-33
73,916
-118
-300
Net cash used provided by (used for) financing activities
23,203
8,352
113,109
2,739
4,939
Net change in cash
-26,790
-46,880
108,024
767
-15,564
Cash at beginning of period
70,059
112,346
4,322
3,555
19,119
Cash at end of period
43,385
65,466
112,346
4,322
3,555
Free cash flow
Operating cash flow
-21,839
-18,717
10,439
-1,939
-23,737
Capital expenditure
-258
-93
-102
-33
-26
Free cash flow
-22,097
-18,810
10,337
-1,972
-23,763